What is the ICD-10-CM code for non-alcoholic steatohepatitis (NASH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Code for NASH

The ICD-10-CM code for non-alcoholic steatohepatitis (NASH) is K75.81 1.

Clinical Context and Coding Considerations

NASH represents the progressive, inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). The diagnosis requires:

  • ≥5% hepatic steatosis (documented by imaging or histology)
  • Hepatocyte injury (ballooning degeneration)
  • Lobular inflammation
  • With or without fibrosis 2

Important Coding Distinctions

When coding for liver disease in this spectrum, recognize these key differences:

Simple steatosis (NAFL) differs from NASH in that it lacks hepatocyte ballooning and has minimal inflammation, carrying negligible risk of progression 3, 2. While the provided evidence doesn't specify a separate ICD-10 code for simple NAFL, K75.81 is specifically designated for the inflammatory form (NASH).

NASH with cirrhosis requires additional coding to capture the advanced fibrosis stage, as the K75.81 code alone does not convey cirrhosis status 2.

Clinical Documentation Requirements

For accurate coding with K75.81, documentation should ideally include:

  • Exclusion of significant alcohol consumption (>21 drinks/week for men, >14 drinks/week for women) 4, 2
  • Exclusion of other secondary causes of hepatic steatosis
  • Evidence of metabolic risk factors (obesity, type 2 diabetes, dyslipidemia, hypertension) 5
  • Liver biopsy confirmation when available, though clinical diagnosis based on imaging plus metabolic risk factors is increasingly accepted 5

Common Coding Pitfalls

Avoid using K75.81 for simple steatosis without inflammation - this overcodes the severity and may trigger inappropriate management pathways.

Document fibrosis stage separately when known, as this critically impacts prognosis and treatment eligibility. Patients with F2-F3 fibrosis may qualify for specific therapies like resmetirom 6, 7.

Ensure metabolic comorbidities are also coded (diabetes, obesity, dyslipidemia), as NASH is fundamentally a metabolic disease and these codes support the diagnosis and justify screening 5, 4.

Related Questions

Why does a 78-year-old male with fatty liver disease, non-alcoholic steatohepatitis (NASH) and ascites require three platelet transfusions, and how can laboratory tests suggest the presence of a tumor?
What is a complete draft protocol for a retrospective cohort study of adult patients with metabolic‑dysfunction‑associated steatotic liver disease (MASLD), including inclusion and exclusion criteria, baseline data collection, imaging assessments, primary and secondary outcomes, statistical analysis plan, sample‑size calculation, data management, and anticipated challenges?
What are the differences between metabolic dysfunction‑associated steatohepatitis (MASH) and non‑alcoholic steatohepatitis (NASH) regarding definition, diagnosis, and management?
What is the recommended treatment for a patient with early non‑alcoholic steatohepatitis (grade 1 steatosis, ~10‑15% involvement) and stage 2 of 4 fibrosis, given chronic liver disease and indeterminate FibroScan findings?
What does the FibroSure NASH test assess for hepatic steatosis?
What are the essential steps and principles for performing surgery safely?
What is the appropriate dosing regimen of esmolol for a hypertensive emergency?
What is the appropriate ICD‑10‑CM code for facial paralysis?
What do a low mean corpuscular volume (≈80 fL), low mean corpuscular hemoglobin (≈27 pg), low neutrophil count (1.77 ×10⁹/L), and low eosinophil count (0.04 ×10⁹/L) suggest?
What is the ICD‑10‑CM code for morbid (severe) obesity?
What is the recommended management for an 83-year-old man with a common bile duct stone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.